Alterations in Polyamine Metabolism in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex 2-Deficient Cells

BACKGROUND: Lymphangioleiomyomatosis (LAM), a destructive lung disease that affects primarily women, is caused by loss-of-function mutations in TSC1 or TSC2, leading to hyperactivation of mechanistic/mammalian target of rapamycin complex 1 (mTORC1). Rapamycin (sirolimus) treatment suppresses mTORC1...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Chest
Autori principali: Tang, Yan, El-Chemaly, Souheil, Taveira-Dasilva, Angelo, Goldberg, Hilary J., Bagwe, Shefali, Rosas, Ivan O., Moss, Joel, Priolo, Carmen, Henske, Elizabeth P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American College of Chest Physicians 2019
Soggetti:
Diffuse Lung Disease
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6904859/
https://ncbi.nlm.nih.gov/pubmed/31299246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2019.05.038
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi